|
CN1871341A
|
|
Methods for enhancing embryo viability
|
|
US2005070478A1
|
|
T cell antigen receptor peptides
|
|
AU2003904283A0
|
|
An implantable direct cardiac compression device and system
|
|
AU2003902981A0
|
|
Immunoprecipitation tube
|
|
AU2002302094A1
|
|
Patient Simulator Manikin and System
|
|
US7021940B2
|
|
Patient simulator manikin and system
|
|
CA2404807A1
|
|
Genetic marker and test
|
|
AUPS236902A0
|
|
Composition and method for treating hypertension
|
|
AUPR333301A0
|
|
Determining the volume of a normal heart and its pathological and treated variants by using dimension sensors
|
|
AUPP635698A0
|
|
Insect pest control
|
|
AU7854898A
|
|
PAPP-A, its immunodetection and uses
|
|
AUPO959597A0
|
|
Insect pest control
|
|
AU4193097A
|
|
Method of cell inhibition using polypeptides derived from the venom of the Australian jumper ant Myrmecia Pilosula
|
|
AUPO745497A0
|
|
Igf binding ternary complex
|
|
AU1584897A
|
|
Chemotherapy resistance gene
|
|
WO9713854A1
|
|
Pilosulin 2
|
|
AU7121296A
|
|
Pilosulin 2
|
|
AUPO255996A0
|
|
Cell inhibition
|
|
AUPO039396A0
|
|
Novel immunomodulatory cd3-epsilon chain peptides
|
|
AUPO039196A0
|
|
Novel immunomodulatory t-cell antigen receptor alpha chain peptides
|
